As filed with the Securities and Exchange Commission on October 2, 2023
Registration No. 333-239987
Registration No. 333-254399
Registration No. 333-263243
Registration No. 333-270041
Registration No. 333-270728
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO.
333-239987
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM
S-8 REGISTRATION STATEMENT NO. 333-254399
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO.
333-263243
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM
S-8 REGISTRATION STATEMENT NO. 333-270041
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO.
333-270728
FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
BRUKER CELLULAR ANALYSIS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
35-2415390 |
(State or other jurisdiction of incorporation or organization) |
|
(IRS employer
identification number) |
5858 Horton Street, Suite 320
Emeryville, California 94608
(Address of principal executive offices)
2011 Equity Incentive Plan
2020 Incentive Award Plan
2020 Employee Stock Purchase Plan
IsoPlexis Corporation 2014 Stock Plan
(Full title of the Plans)
J. Brent Alldredge
Secretary
Bruker
Cellular Analysis, Inc.
40 Manning Road
Billerica, MA 01821
(Name
and address of Agent for Service)
(978) 663-3660 (Telephone number, including area code, of
agent for service)
Copies to:
Laurie A. Cerveny
Robert
W. Dickey
Bryan S. Keighery
Morgan, Lewis & Bockius LLP
One Federal Street
Boston, Massachusetts 02110
Telephone: (617) 341-7700
Fax: (617) 341-7701
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, a smaller reporting company, or an emerging growth company. See definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐